Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes

Marika Bogdani, Eva Korpos, Charmaine J. Simeonovic, Christopher R. Parish, Lydia Sorokin, Thomas N. Wight*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    73 Citations (Scopus)

    Abstract

    Type 1 diabetes (T1D) results from progressive immune cell-mediated destruction of pancreatic β cells. As immune cells migrate into the islets, they pass through the extracellular matrix (ECM). This ECM is composed of different macromolecules localized to different compartments within and surrounding islets; however, the involvement of this ECM in the development of human T1D is not well understood. Here, we summarize our recent findings from human and mouse studies illustrating how specific components of the islet ECM that constitute basement membranes and interstitial matrix of the islets, and surprisingly, the intracellular composition of islet β cells themselves, are significantly altered during the pathogenesis of T1D. Our focus is on the ECM molecules laminins, collagens, heparan sulfate/heparan sulfate proteoglycans, and hyaluronan, as well as on the enzymes that degrade these ECM components. We propose that islet and lymphoid tissue ECM composition and organization are critical to promoting immune cell activation, islet invasion, and destruction of islet β cells in T1D.

    Original languageEnglish
    Article number552
    Pages (from-to)1-11
    Number of pages11
    JournalCurrent Diabetes Reports
    Volume14
    Issue number12
    DOIs
    Publication statusPublished - 26 Oct 2014

    Fingerprint

    Dive into the research topics of 'Extracellular Matrix Components in the Pathogenesis of Type 1 Diabetes'. Together they form a unique fingerprint.

    Cite this